Cardiol Therapeutics Stock Quote CRDL - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.62

Bid

1.50

Ask

1.62

Volume

285,282

1.57 Day's Range 1.6999

0.7912 52 Week Range 3.12

Market Cap

113.208M

Previous Close

1.58

Open

1.60

Last Trade

100

1.610772

(average)

Last Trade Time

Financial Volume

$ 460,444

VWAP

1.614

Average Volume (3m)

497,301

Shares Outstanding

69,881,720

Dividend Yield

PE Ratio

-5.59

Earnings Per Share (EPS)

-0.4

Revenue

Net Profit

-28.13M

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solut... Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. Show more

Sector

Coml Physical, Biologcl Resh

Industry

Coml Physical, Biologcl Resh

Headquarters

Oakville, Ontario, Can

Founded

Cardiol Therapeutics Inc is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker CRDL. The last closing price for Cardiol Therapeutics was $1.58. Over the last year, Cardiol Therapeutics shares have traded in a share price range of $ 0.7912 to $ 3.12.

Cardiol Therapeutics currently has 69,881,720 shares outstanding. The market capitalization of Cardiol Therapeutics is $110.41 million. Cardiol Therapeutics has a price to earnings ratio (PE ratio) of -5.59.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.01	0.621118012422	1.61	1.65	1.49	341750	1.56744106	CS
4	-0.23	-12.4324324324	1.85	2.24	1.49	438535	1.78108638	CS
12	-0.25	-13.3689839572	1.87	2.63	1.49	497301	1.93027921	CS
26	-0.72	-30.7692307692	2.34	3.12	1.49	459563	2.10491862	CS
52	0.72	80	0.9	3.12	0.7912	387475	1.9150206	CS
156	-0.56	-25.6880733945	2.18	3.12	0.45	276238	1.56318159	CS
260	-1.01	-38.4030418251	2.63	4.96	0.45	332597	2.04414376	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BSLKBolt Projects Holdings Inc	$ 0.71 (139.86%)	80.81M
PRZOParaZero Technologies Ltd	$ 1.24 (94.14%)	205.02M
AIEVThunder Power Holdings Inc	$ 0.47 (87.25%)	122.71M
PASGPassage Bio Inc	$ 1.13 (69.52%)	15.44M
EPOWSunrise New Energy Company Ltd	$ 1.06 (45.21%)	314.9k
APLTApplied Therapeutics Inc	$ 2.03 (-76.31%)	43.9M
TGLTreasure Global Inc	$ 0.2944 (-29.08%)	1.85M
PROCProcaps Group SA	$ 1.51 (-27.75%)	106.08k
SHOTWSafety Shot Inc	$ 0.104 (-20.00%)	1.43k
MONDMondee Holdings Inc	$ 0.7102 (-19.59%)	297.63k
PRZOParaZero Technologies Ltd	$ 1.24 (94.14%)	205.02M
NVDANVIDIA Corporation	$ 138.25 (2.15%)	141.86M
AIEVThunder Power Holdings Inc	$ 0.47 (87.25%)	122.71M
RGTIRigetti Computing Inc	$ 3.05 (27.08%)	116.98M
MARAMARA Holdings Inc	$ 27.42 (1.86%)	89.54M